Apollo Hospitals recorded 11 per cent increase in standalone net profit at ₹78.9 crore for the September quarter against ₹70.9 crore net profit made during the corresponding period last year.

The company’s standalone revenue grew by 15 per cent to ₹2,090 crore (₹1,813 crore) primarily driven by better volume growth from new and existing hospitals.

On a segmental basis, revenue from healthcare services grew by 11.4 per cent at ₹1,127 crore (₹1011 crore) for the September quarter while Pharmacy revenue grew by 20 per cent to ₹964 crore (₹802 crore) on a year-on-year basis.

“We are pleased to report a robust operational performance which reflects the inherent strength of our service model,” said Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Limited (AHEL).

On a consolidated basis, the company’s net profit recorded a 27 per cent increase at ₹61.8 crore(₹48.7 crore) for the quarter against a 15 per cent growth in revenue at ₹2,400 crore(₹2,089 crore).

In a bid to reorganise its standalone pharmacy business for a potential ‘value discovery’ of the business at a later stage, the Board of AHEL segregation of front-end retail pharmacy business into a separate company called ‘Apollo Pharmacies Limited’.

“APL will focus on a multi-year growth platform for the stand-alone pharmacies business to get to a medium-term target of over 5,000 pharmacy outlets over 5 years with a goal of over ₹10,000 crore in revenues and 30 per cent combined ROCE,” the company said.

AHEL will make a slump sale transfer of its front-end retail pharmacy business carried out through the standalone pharmacy segment to APL for ₹527.8 crore, the company said in a regulatory filing.

Related Topics
comment COMMENT NOW